Although previous studies have suggested reduced tissue BMP9 expression [34] and increased serum sEng levels in hepatocellular carcinoma patients [33,35], we did not observe any difference in levels of BMP9, pBMP10 and sEng between patients with cirrhosis and with HCC (eFigure 3). This evidence concerns the gene GDF2 and Cirrhosis.